Wellington Management Group’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.88M Sell
672,144
-227,844
-25% -$1.27M ﹤0.01% 1495
2025
Q4
$8.06M Buy
899,988
+31,458
+4% +$195K ﹤0.01% 1305
2025
Q3
$3.21M Buy
868,530
+134,988
+18% +$368K ﹤0.01% 1529
2025
Q2
$1.43M Buy
733,542
+40,869
+6% +$85.1K ﹤0.01% 1656
2025
Q1
$1.22M Buy
692,673
+16,649
+2% +$37.9K ﹤0.01% 1663
2024
Q4
$1.8M Buy
676,024
+52,051
+8% +$134K ﹤0.01% 1590
2024
Q3
$1.43M Buy
623,973
+283,642
+83% +$865K ﹤0.01% 1641
2024
Q2
$994K Buy
+340,331
New +$1.04M ﹤0.01% 1679
2021
Q2
Sell
-808,325
Closed -$8.22M 2208
2021
Q1
$8.22M Buy
+808,325
New +$9.04M ﹤0.01% 1294

Other funds holding NUVB

Wellington Management Group's NUVB Position: Q1 2026 in Review

Wellington Management Group reduced its Nuvation Bio (NUVB) stake by 25% in Q1 2026, selling an estimated $1.27M and leaving 672,144 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

Wellington Management Group first reported a position in NUVB in Q1 2021 and has held it in 9 quarters since. The position peaked at $8.22M in Q1 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Wellington Management Group held 672,144 shares of Nuvation Bio worth $2.88M as of Q1 2026.
  • Wellington Management Group sold 227,844 Nuvation Bio shares in Q1 2026, an estimated $1.27M.
  • Nuvation Bio made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1495 holding.
  • Wellington Management Group first reported a position in Nuvation Bio in Q1 2021 and has held it in 9 quarters since.
  • Wellington Management Group's Nuvation Bio position peaked at $8.22M in Q1 2021.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.